Nock B, Sedvall G, Mcewen B S
Eur J Pharmacol. 1986 Mar 4;121(3):387-93. doi: 10.1016/0014-2999(86)90259-1.
(-)Piquindone is a new antipsychotic pyrroloisoquinoline derivative that binds to dopamine D2 receptors. We used in vitro quantitative autoradiography to determine the distribution of 3Hpiquindone binding sites in rat forebrain. 3HPiquindone binding to brain slices was sodium dependent, saturable and of high affinity (Kd = 5 nM at 0 degree C). In autoradiographic experiments, there was a good signal to noise ratio for 3Hpiquindone binding with nonspecific binding representing only about 20% of total binding in caudate putamen. The D2 antagonists (-)sulpiride and raclopride were much more potent inhibitors of 3Hpiquindone binding than the D1 antagonist SCH 23390. Dopamine inhibited binding with a potency similar to that previously found with standard membrane binding procedures. Autoradiography indicated that binding sites 3Hpiquindone are localized to olfactory tubercle, accumbens nucleus, caudate putamen, cell bridges between caudate putamen and olfactory tubercle, and substantia nigra. Binding in these areas is stereoselective since we found no specific binding with 3Hpiquindone, the biologically inactive enantiomer. Within caudate putamen, there was a lateral to medial gradient in the optical density of 3Hpiquindone autoradiograms which might, in part, be attributable to white matter density rather than to D2 receptors.
(-)匹喹酮是一种新型抗精神病吡咯并异喹啉衍生物,可与多巴胺D2受体结合。我们采用体外定量放射自显影法来确定[3H](-)匹喹酮结合位点在大鼠前脑的分布。[3H](-)匹喹酮与脑切片的结合是钠依赖性的、可饱和的且具有高亲和力(0℃时Kd = 5 nM)。在放射自显影实验中,[3H](-)匹喹酮结合的信噪比良好,尾状核壳核中非特异性结合仅占总结合的约20%。D2拮抗剂(-)舒必利和雷氯必利对[3H](-)匹喹酮结合的抑制作用比D1拮抗剂SCH 23390更强。多巴胺抑制结合的效力与先前通过标准膜结合程序所发现的相似。放射自显影表明,[3H](-)匹喹酮结合位点定位于嗅结节、伏隔核、尾状核壳核、尾状核壳核与嗅结节之间的细胞桥以及黑质。由于我们未发现[3H](+)匹喹酮(生物活性无活性对映体)有特异性结合,所以这些区域的结合具有立体选择性。在尾状核壳核内,[3H](-)匹喹酮放射自显影片的光密度存在从外侧到内侧的梯度,这可能部分归因于白质密度而非D2受体。